Are These Stocks Showing Potential? Supernus Pharmaceuticals Inc (SUPN), Insmed Incorporated (INSM) and Relypsa Inc (RLYP)

Posted by admin April 28, 2015 0 Comment 601 views

New York, NY – GDP INSIDER  –  04/28/2014.

This article discusses three companies: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Insmed Incorporated (NASDAQ:INSM) and Relypsa Inc (NASDAQ:RLYP)

Supernus Pharmaceuticals Inc (NASDAQ:SUPN) continued to fall yesterday with the stock declining 5.16% or $0.71 to finish its last trading session on higher than average trading volume of 0.993 million compared with its three month average trading volume of 0.568 million. The Rockville-based pharmaceutical company, which focuses on the development and commercialization of products for central nervous system diseases, is holding well above its 50 day moving average of $11.26 and 200 day moving average of $9.26. With RSI of 57.83 and quick ratio of 3.50, the stock has medium to long term potential, hold.

Do Fundamentals Of Supernus Pharmaceuticals Inc Support High Gains? Read Our Free SUPN Analysis For Free To Know More.

Insmed Incorporated (NASDAQ:INSM) continued to decline yesterday as the stock fell $1.30 to finish the day at $21.96, a 5.59% decrease in value from its previous closing price of $23.25 on slightly higher than average trading volume of 0.559 million compared with its three month average trading volume of 0.559 million. The US based inhaled therapies developer for serious lung diseases has been having a good year so far with the stock gaining 41.89% YTD, compared to the S&P 500 index which has gained 2.43% over the same period. The RSI of 51.99 shows the stock is not undervalued at the current levels, the MFI of 57.27 indicates the money is flowing in the right direction, hold.

Do Technical Indicators Support Further Gains For Insmed Incorporated? Find Our More In Our Free INSM Investment Analysis.

Relypsa Inc (NASDAQ:RLYP) continued its bearish trend yesterday with the stock losing an additional 5.63% or $1.96 to close the day at $32.87 with only 0.374 million shares changing hands compared to its three month average trading volume of 0.543 million. Despite yesterday’s loss, the stock is trading 86.76% above its 52 week low of $17.60. With a one year target estimate of $58.50 and RSI of 33.82, there is plenty of upside potential in the stock making it a solid hold with a view to buy at this time.

Can Relypsa Inc Push Past Its Target Estimate? Click Here For Our Free RLYP Analysis.

About Ultimate Stock Alerts covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit

Disclosure: is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment